ArticleBritish journal of cancer2012

A phase I study of E7080, a multitargeted tyrosine kinase inhibitor, in patients with advanced solid tumours.

D S Boss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.